14 Nov
CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine
Two radically new gene based immunotherapies were approved by the FDA this year - Kymriah followed by Yescarta - in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) - it was known as CTL019. Kymriah was approved for treatment...